Medicare Enrolled
Dr. Ben Chue, M.D.
Hematology & Oncology · Seattle, WA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chue from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chue?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chue
Dr. Ben Chue is a hematology & oncology specialist in Seattle, WA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Chue performed 33,087 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Chue received a total of $23,893 from 98 pharmaceutical and/or device companies across 1068 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chue is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 10% volume in WA
$23,893 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗33,087
Medicare services
Top 10% in WA for hematology & oncology
Not available
Unique patients (not deduplicated)
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Paclitaxel chemotherapy injection | 17,571 | $0 | $0 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
5,172 | $0 | $0 |
| Anti-nausea injection (Aloxi/palonosetron) | 3,020 | $1 | $23 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
1,456 | $14 | $64 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
894 | $1 | $4 |
| Injection, potassium chloride, per 2 meq | 712 | $0 | $0 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
479 | $27 | $100 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
422 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
408 | $106 | $196 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
334 | $2 | $2 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
313 | $1 | $1 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
304 | $1 | $9 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
289 | $60 | $200 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
288 | $123 | $409 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
253 | $52 | $168 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
248 | $1 | $4 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
210 | $12 | $44 |
| 5% dextrose/water (500 ml = 1 unit) | 182 | $1 | $4 |
| Injection, leucovorin calcium, per 50 mg | 168 | $3 | $5 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
116 | $65 | $125 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
101 | $2 | $4 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
80 | $57 | $183 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
50 | $12 | $47 |
| New patient office visit, complex (60-74 min) | 17 | $181 | $340 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
7.2% high complexity
89.6% medium
3.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$23,893
Total received (2018-2024)
Avg $3,413/year across 7 years
Top 15% in WA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
98
Companies
1,068
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,107
2023
$4,212
2022
$3,210
2021
$2,345
2020
$2,218
2019
$4,501
2018
$3,300
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$301
PFIZER INC.
$279
TAIHO ONCOLOGY, INC.
$233
Lilly USA, LLC
$229
EMD Serono, Inc.
$217
Novartis Pharmaceuticals Corporation
$198
Takeda Pharmaceuticals U.S.A., Inc.
$194
Genmab U.S., Inc.
$190
ARRAY BIOPHARMA INC
$186
Astellas Pharma US Inc
$178
GlaxoSmithKline, LLC.
$166
Gilead Sciences, Inc.
$148
TerSera Therapeutics LLC
$128
Amgen Inc.
$125
AIMMUNE THERAPEUTICS, INC.
$106
Daiichi Sankyo Inc.
$105
Celgene Corporation
$103
Tempus AI, Inc
$100
Coherus Biosciences Inc.
$93
Organon Llc
$75
Bayer Healthcare Pharmaceuticals Inc.
$70
Incyte Corporation
$70
Rigel Pharmaceuticals, Inc.
$64
SOBI, INC
$63
Genentech USA, Inc.
$56
Regeneron Healthcare Solutions, Inc.
$47
ACCORD HEALTHCARE, INC.
$37
Stemline Therapeutics Inc.
$33
Blueprint Medicines Corporation
$31
Deciphera Pharmaceuticals Inc.
$28
Eisai Inc.
$25
Ipsen Biopharmaceuticals, Inc
$25
Janssen Biotech, Inc.
$25
Aveo Pharmaceuticals, Inc.
$24
SUN PHARMACEUTICAL INDUSTRIES INC.
$24
Acrotech Biopharma Inc.
$24
Pharmacosmos Therapeutics Inc.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Agios Pharmaceuticals, Inc.
$20
Myriad Genetic Laboratories, Inc.
$20
Adaptive Biotechnologies Corporation
$18
Top 3 companies account for 19.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,784
PFIZER INC.
$1,703
Janssen Biotech, Inc.
$1,644
E.R. Squibb & Sons, L.L.C.
$1,138
Lilly USA, LLC
$971
Amgen Inc.
$874
GlaxoSmithKline, LLC.
$685
Takeda Pharmaceuticals U.S.A., Inc.
$645
Seagen Inc.
$644
Boehringer Ingelheim Pharmaceuticals, Inc.
$506
Merck Sharp & Dohme Corporation
$483
Eisai Inc.
$440
ARRAY BIOPHARMA INC
$436
Astellas Pharma US Inc
$424
Novartis Pharmaceuticals Corporation
$422
Janssen Pharmaceuticals, Inc
$408
EMD Serono, Inc.
$408
Gilead Sciences, Inc.
$403
Seattle Genetics, Inc.
$401
Genentech USA, Inc.
$397
TerSera Therapeutics LLC
$372
Celgene Corporation
$365
Daiichi Sankyo Inc.
$355
Pharmacyclics LLC, An AbbVie Company
$346
Clovis Oncology, Inc.
$326
Genmab U.S., Inc.
$298
TAIHO ONCOLOGY, INC.
$296
Octapharma USA, Inc.
$288
Taiho Oncology, Inc.
$288
Merck Sharp & Dohme LLC
$275
Organon LLC
$264
GENZYME CORPORATION
$250
TESARO, Inc.
$243
EISAI INC.
$243
MorphoSys, US Inc.
$233
Incyte Corporation
$231
MACROGENICS, INC.
$222
Bayer HealthCare Pharmaceuticals Inc.
$214
Helsinn Therapeutics (U.S.), Inc.
$198
Coherus Biosciences Inc.
$195
Blueprint Medicines Corporation
$170
G1 Therapeutics, Inc.
$166
Kite Pharma, Inc.
$145
Foundation Medicine, Inc.
$144
SOBI, INC
$143
Pharmacyclics LLC, an AbbVie Company
$125
AVEO Pharmaceuticals, Inc.
$119
Mylan Institutional Inc.
$119
Heron Therapeutics, Inc.
$116
Exelixis Inc.
$109
AIMMUNE THERAPEUTICS, INC.
$106
Tempus AI, Inc
$100
Deciphera Pharmaceuticals Inc.
$98
Ipsen Biopharmaceuticals, Inc
$91
Rigel Pharmaceuticals, Inc.
$88
Regeneron Healthcare Solutions, Inc.
$87
Bayer Healthcare Pharmaceuticals Inc.
$86
AbbVie Inc.
$77
Organon Llc
$75
Agios Pharmaceuticals, Inc.
$74
Fortovia Therapeutics, Inc.
$68
Alexion Pharmaceuticals, Inc.
$66
Puma Biotechnology, Inc.
$65
JAZZ PHARMACEUTICALS INC.
$65
Mirati Therapeutics, Inc.
$61
Acrotech Biopharma Inc.
$60
Aadi Bioscience, Inc.
$53
Stemline Therapeutics Inc.
$53
CTI BioPharma Corp.
$48
Epizyme, Inc.
$46
Acceleron Pharma, Inc.
$45
Pharmacosmos Therapeutics Inc.
$45
Partner Therapeutics, Inc.
$45
Dova Pharmaceuticals
$38
ACCORD HEALTHCARE, INC.
$37
Aveo Pharmaceuticals, Inc.
$37
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$33
Apellis Pharmaceuticals, Inc.
$32
ABBVIE INC.
$31
Shield Therapeutics Inc
$31
BeiGene USA, Inc.
$30
Fresenius Kabi USA, LLC
$30
Amneal Pharmaceuticals LLC
$26
SUN PHARMACEUTICAL INDUSTRIES INC.
$24
Dendreon Pharmaceuticals LLC
$24
AbbVie, Inc.
$23
ADMA BioManufacturing LLC
$23
Karyopharm Therapeutics Inc.
$22
Sun Pharmaceutical Industries Inc.
$20
Myovant Sciences Inc.
$20
Myriad Genetic Laboratories, Inc.
$20
Adaptive Biotechnologies Corporation
$18
INSYS Therapeutics Inc
$18
ADC Therapeutics America, Inc.
$17
Sirtex Medical Inc
$17
Pharming Healthcare, Inc.
$16
Novocure Inc.
$15
Roche Diagnostics Corporation
$14
Top 3 companies account for 21.5% of all-time payments
Associated products mentioned in payments ›
6 · ABECMA · ACCRUFER · ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BALVERSA · BAVENCIO · BELEODAQ · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CAMCEVI · CINVANTI · COSELA · CRESEMBA · CYRAMZA · Cabometyx · Cresemba · DARZALEX · DIFICID · DIS Navify Software · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · EXKIVITY · Empaveli · Enhertu · Epkinly · Erleada · FASLODEX · FOTIVDA · FOUNDATIONONE CDX · FRUZAQLA · Fabhalta · Fulphila · Fyarro · GAVRETO · GAZYVA · GILOTRIF · Halaven · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Inrebic · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · Lunsumio · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · MVASI · NERLYNX · NEUPOGEN · NEXPLANON · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONGLYZA · ONTRUZANT · OPDIVO · ORGOVYX · Odomzo · Ogivri · Oncology · Onivyde · Orserdu · PADCEV · PANZYGA · PIQRAY · PLUVICTO · PRECISETUMOR · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Prolia · QINLOCK · Quzyttir · REBLOZYL · RETEVMO · RUCONEST · Reblozyl · Revlimid · Rezlidhia · Rubraca · SARCLISA · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SUSTOL · SUTENT · SYNDROS · Stimufend · Stivarga · TAGRISSO · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · VONJO · VOWST · VPRIV · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XIFAXAN · XIFIXAN · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · YONSA · Yescarta · ZEJULA · ZENPEP · ZEPZELCA · ZYKADIA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
268
County median income
$122,148
Nearest hospital to ZIP centroid (approximate)
UNIVERSITY OF WASHINGTON MEDICAL CTR
1.5 mi
1.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chue is a mixed practice specialist, with above-average Medicare volume (top 10% in WA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chue experienced with paclitaxel chemotherapy injection?
Based on Medicare claims data, Dr. Chue performed 17,571 paclitaxel chemotherapy injection services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Chue receive payments from pharmaceutical companies?
Yes. Dr. Chue received a total of $23,893 from 98 companies across 1,068 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chue's costs compare to other hematology & oncology specialists in Seattle?
Dr. Chue's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chue) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Seattle
Browse hematology & oncology specialists in Seattle ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in WA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in WA
Which WA hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology